Risks of Decompression Sickness and Venous Thromboembolism during Spaceflight and Patent Foramen Ovale Implications
Illustration
AI Summary
NASA’s Office of the Chief Health and Medical Officer formed a working group in August 2026 to review the most recent data related to extravehicular activity (EVA) prebreathe testing and decompression sickness (DCS) events, venous thromboembolism (VTE) in-flight occurrences, and patent foramen ovale (PFO) implication as they relate to NASA’s Artemis (lunar and beyond) missions. Newsiline summarises this report from NASA - News Releases and links readers to the original publisher for the full story.
Key Points
- Original report published by NASA - News Releases.
- Newsiline stores only headline metadata, source credit, and a short summary.
- Readers are directed to the publisher for the complete article.
Why It Matters
This story may affect readers following the category, country, or source involved. Newsiline keeps the summary neutral and points to the publisher for full context.
Sources
NASA - News Releases: Read full story at source
Newsiline provides short summaries and links to publishers. It does not republish full articles.